Long-acting injectable antiretrovirals are currently available for treatment of HIV, and approval for HIV prevention is anticipated soon; these developments may significantly change the landscape of HIV treatment and prevention. In this case-based webinar, Dr. Kevin Ard will discuss injectable antiretrovirals for HIV treatment and prevention. By the end of the webinar, participants will be familiar with the most up-to-date evidence for injectable antiretrovirals and will be able to describe programmatic changes that may be necessary to implement long-acting injectable medications in clinical practice.
Many sexual and gender minority people eligible for or taking HIV pre-exposure prophylaxis (PrEP) are at risk for sexually transmitted infections (STIs) and testing and treating STIs are key aspects of providing PrEP. In this clinically focused, case-based webinar, Dr. Kevin Ard will describe important updates in STI management for PrEP patients, based on the 2021 STI Treatment Guidelines from CDC.
Participants of this webinar will discover strategies for engaging internal and community resources for supporting older LGBTQIA+ patients during a pandemic. Facilitators from The LGBTQIA+ Aging Project will discuss methods for connecting with communities, and best practices for attending to the mental health and social determinants of health needs of LGBTQIA+ older adults during COVID-19.
In this talk from the 2021 Advancing Excellence in Transgender Health conference, Dr. Poteat reviews data on PrEP among transgender people, outlines current guidelines for PrEP use, and describes gender-affirming practices for PrEP implementation.
In this talk from the 2021 Advancing Excellence in Transgender Health conference, Dr. Deutsch covers primary care and preventative health needs for transgender and non-binary people.
In this talk from the 2021 Advancing Excellence in Transgender Health conference, Cei Lambert focuses particularly on provider bias and power dynamics and how bias shows up for transgender and gender-diverse clients.